Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Hande

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Seminars in Oncology|December 1, 1992
Etoposide pharmacologyK R Hande
Current Opinion in Oncology|December 1, 1992
Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloidsK R Hande
Stem Cells (Dayton, Ohio)|January 1, 1996
The importance of drug scheduling in cancer chemotherapy: etoposide as an exampleK R Hande
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Pharmacologic-based dosing of carboplatin: a better methodK R Hande
Journal of the National Cancer Institute|November 6, 1991
Drug monitoring in cancer therapyK R Hande
Biochimica Et Biophysica Acta|September 28, 1998
Clinical applications of anticancer drugs targeted to topoisomerase IIK R Hande
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Etoposide: four decades of development of a topoisomerase II inhibitorK R Hande
The American Journal of the Medical Sciences|October 1, 1986
Evaluation of a thiazide-allopurinol drug interactionK R Hande
Analytical Biochemistry|January 1, 1980
A competitive protein binding assay for allopurinol and oxipurinolK R Hande, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Topoisomerase II inhibitorsT R Toonen, K R Hande
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Seminars in Oncology|December 1, 1992
Etoposide pharmacologyK R Hande
Current Opinion in Oncology|December 1, 1992
Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloidsK R Hande
Stem Cells (Dayton, Ohio)|January 1, 1996
The importance of drug scheduling in cancer chemotherapy: etoposide as an exampleK R Hande
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Pharmacologic-based dosing of carboplatin: a better methodK R Hande
Journal of the National Cancer Institute|November 6, 1991
Drug monitoring in cancer therapyK R Hande
Biochimica Et Biophysica Acta|September 28, 1998
Clinical applications of anticancer drugs targeted to topoisomerase IIK R Hande
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Etoposide: four decades of development of a topoisomerase II inhibitorK R Hande
The American Journal of the Medical Sciences|October 1, 1986
Evaluation of a thiazide-allopurinol drug interactionK R Hande
Analytical Biochemistry|January 1, 1980
A competitive protein binding assay for allopurinol and oxipurinolK R Hande, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Topoisomerase II inhibitorsT R Toonen, K R Hande
Pageof 11